Credit Suisse Ag Recursion Pharmaceuticals, Inc. Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

A detailed history of Credit Suisse Ag transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Credit Suisse Ag holds 1,936,970 shares of RXRX stock, worth $13.3 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

1,936,970

Previous 1,702,056 13.8%

Holding current value

$13.3 Million

Previous $16.8 Million 15.07%

% of portfolio

0.02%

Previous 0.02%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$9.13 - $15.52 $2.14 Million - $3.65 Million	234,914 Added 13.8%	1,936,970 $19.3 Million
Q4 2023 Feb 08, 2024	BUY	$5.09 - $10.79 $77,215 - $163,684	15,170 Added 0.9%	1,702,056 $16.8 Million
Q3 2023 Nov 13, 2023	SELL	$6.59 - $15.86 $85,702 - $206,259	-13,005 Reduced 0.77%	1,686,886 $12.9 Million
Q2 2023 Aug 11, 2023	BUY	$4.56 - $9.94 $535,882 - $1.17 Million	117,518 Added 7.43%	1,699,891 $12.7 Million
Q1 2023 May 10, 2023	BUY	$6.42 - $9.64 $43,546 - $65,388	6,783 Added 0.43%	1,582,373 $10.6 Million
Q4 2022 Feb 13, 2023	BUY	$7.16 - $12.7 $73,282 - $129,984	10,235 Added 0.65%	1,575,590 $12.1 Million
Q3 2022 Nov 10, 2022	BUY	$7.83 - $13.6 $2,364 - $4,107	302 Added 0.02%	1,565,355 $16.7 Million
Q2 2022 Aug 12, 2022	BUY	$5.04 - $9.26 $2,273 - $4,176	451 Added 0.03%	1,565,053 $12.7 Million
Q1 2022 May 16, 2022	BUY	$6.16 - $18.03 $30,701 - $89,861	4,984 Added 0.32%	1,564,602 $11.2 Million
Q4 2021 Feb 14, 2022	BUY	$16.14 - $21.86 $1.76 Million - $2.38 Million	109,022 Added 7.52%	1,559,618 $26.7 Million
Q3 2021 Nov 12, 2021	BUY	$19.03 - $41.33 $19,239 - $41,784	1,011 Added 0.07%	1,450,596 $33.4 Million
Q2 2021 Aug 16, 2021	BUY	$18.0 - $37.42 $26.1 Million - $54.2 Million	1,449,585 New	1,449,585 $52.9 Million

Others Institutions Holding RXRX

# of Institutions

286

Shares Held

242M

Call Options Held

1.35M

Put Options Held

2.32M

View Full List

About RECURSION PHARMACEUTICALS, INC.

Ticker RXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 180,480,000
Market Cap $1.24B
Description
Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...

More about RXRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account